Medstar Georgetown University Hospital
Locations
Transplant Summary
Overview
Our Stem Cell Transplant and Immunotherapy Program is the only adult academic program of its kind in the Washington D.C area giving patients access to life-saving treatment options not otherwise available in our region. Our transplant specialists have extensive experience performing stem cell transplants and administering cellular immunotherapy. We work to provide a safe effective and comfortable experience for patients. Many patients who may have been turned away from other programs-either due to age, health, or other reasons-often find hope and treatment here.This center has been performing allogeneic transplants since 2016 and has been an NMDP transplant center since May 2018.
Attending physicians
Adult - Alaa Ali, Jennifer Kanakry, Andrew Pecora, David VesoleTransplants performed
Marrow/PBSC onlyCord blood transplants
Not performedOther programs and services
Our program works with area hotels to obtain discounted lodging rates for patients. We offer caregiver support and assistance and can assist with transportation.Patient survival information for this center
This center's actual 1-year survival results are similar to the expected rate for this center*.The survival information we have for this center includes ONLY:- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 35 patients.The actual 1-year survival of these patients is 80%.Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 65.5% and 91.1%.For help with understanding these statistics, please see Understanding Transplant Outcomes.For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report (Opens in a new tab) at bloodcell.transplant.hrsa.gov.* The expected survival rate for a transplant center can be below, similar to, or above the range listed. This is based on comparing patient survival at all centers that treated patients with similar diseases.
The survival rate cannot tell how you will do with your transplant. Talk to your doctor to understand your prognosis or the likely course of your disease.
Total adult transplants
144
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow2PBSC18Cord blood0Total20Unrelated donorMarrow0PBSC14Cord blood0Total14Total allogeneicMarrow2PBSC32Cord blood0Total34AutologousMarrowBoth marrow & PBSC 110PBSC—Cord blood—Total110Total combinedMarrowBoth marrow & PBSC 144PBSC—Cord blood0Total144All Diseases
Number of transplants by age reported from January 1, 2022 to December 31st, 2023(includes marrow, PBSC and cord blood)
0-18 19-44 45-64 65+ Total Related 0-18019-44645-641165+2Total19Unrelated 0-18019-44145-64765+6Total14Autologous 0-18019-44545-646565+40Total110Total 0-18019-441245-648365+48Total143Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants can be found:
- U.S. Transplant Data by Center (Opens in a new tab) report at blood cell.transplant.hrsa.gov
- List of diseases
Transplant center resources
Transplant center coordinatorRavi MohabirPhone: (202) 444-0993If you have questions about costs and financial services at this center, please call the transplant center’s direct phone number.NMDP patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
- Inside the United States: 1 (888) 999-6743
- Outside the United States: 1 (763) 406-3410. (Long distance or international charges may apply.)
Email: patientinfo@nmdp.org
More resources
- Choosing a transplant center
- Preparing for transplant
- Learn about transplant outcomes and treatment decisions (Opens in a new tab)
- Support and resources (including non-English materials)
- U.S. Transplant Data by Center (Opens in a new tab) at blood cell.transplant.hrsa.gov
Medstar Georgetown University Hospital
3800 Reservoir Rd, NW D.C., WA 20007 Phone:202-444-3736 For more information about this program: https://www.medstargeorgetown.org/our-services/cancer-care/stem-cell-transplant-and-cellular-immunotherapy/ (Opens in a new tab)Overview
Our survivorship program offers comprehensive services to patients that have undergone transplant and require routine follow-up care and monitoring. The survivorship team consists of an attending BMT physician working alongside our BMT nurse practitioner. Our patients are able to complete physician/NP visits, and all required laboratory and diagnostic testing at one facility, Medstar Georgetown University Hospital. Additionally, our survivorship program has the ability to make referrals for patients to specialty providers as needed.
Staff
Program Director:Scott D. Rowley, MD , FACPProgram Coordinator:Pashna N. Munshi, MDMedical Specialties in Program
Allergy/immunology, cardiology, complementary and alternative medicine, dermatology, endocrinology, gastroenterology, general surgery, gynecology, hematology, hepatology, infectious disease, nephrology, neurology, oncology, ophthalmology/optometry, orthopedics, otolaryngology, palliative care, psychiatry/psychology, pulmonology, rheumatology, urology.Medical Services Offered
Chronic GVHD management, financial counseling, genetic counseling, nutrition/dietetics, occupational therapy, pain management, physical therapy and rehabilitation, social services, vaccinations.Telemedicine services are available.Patient Eligibility
Adults- Allogeneic and Autologous transplant recipients
- Adults: 6 months after transplant.
- Adults (over age 18)
- Will provide care to adult patients who underwent transplant as a child
- Does accept patients who were transplanted at another hospital